Icu Medical (ICUI) Cash & Equivalents (2009 - 2026)

Icu Medical (ICUI) has 18 years of Cash & Equivalents data on file, last reported at $288.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed 0.47% year-over-year to $288.3 million; the trailing twelve-month figure through Mar 2026 stood at $288.3 million (changed 0.47% YoY), and the FY2025 full-year result was $308.0 million, changed 0.2% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $288.3 million, down from $308.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $329.4 million in Q1 2022 and bottomed at $195.9 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $288.3 million (2026), against an average of $268.6 million.
• The widest annual swing landed in 2022, when Cash & Equivalents plunged 62.23%; it then soared 58.48% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $208.8 million in 2022, then grew by 21.76% to $254.2 million in 2023, then rose by 21.38% to $308.6 million in 2024, then retreated by 0.2% to $308.0 million in 2025, then fell by 6.38% to $288.3 million in 2026.
• The last three Cash & Equivalents figures came in at $288.3 million (Q1 2026), $308.0 million (Q4 2025), and $299.7 million (Q3 2025), per Business Quant data.

Peer Comparison